Intratumoral heterogeneity in cancer progression and response to immunotherapy
Cet article identifie les principales sources d'hétérogénéité intratumorale et analyse leur impact sur l'évolution des tumeurs et la sensibilité des cellules cancéreuses à l'immunothérapie
Most (if not all) tumors emerge and progress under a strong evolutionary pressure imposed by trophic, metabolic, immunological, and therapeutic factors. The relative impact of these factors on tumor evolution changes over space and time, ultimately favoring the establishment of a neoplastic microenvironment that exhibits considerable genetic, phenotypic, and behavioral heterogeneity in all its components. Here, we discuss the main sources of intratumoral heterogeneity and its impact on the natural history of the disease, including sensitivity to treatment, as we delineate potential strategies to target such a detrimental feature of aggressive malignancies.